Swiss Cancer Center Léman (SCCL)

Connected institutions, collaborative specialisations

The Swiss Cancer Center Léman (SCCL) is an alliance created by and amongst the leading institutions that are the : University hospital of Lausanne (CHUV), the University hospitals of Geneva (HUG), the Universities of Lausanne and Geneva, the Swiss Federal Institute of Technology in Lausanne (EPFL) and its privileged partners (see below).

Under a single inclusive identity, this consortium brings together the region's key actors in cancer care, from bench to bedside. 

By focusing efforts on the leading edge of their respective fields, the objective of the alliance members is to develop precision and predictive medical care, one that will recast the treatment of cancer patients.  

Management committee

George Coukos

Pr George Coukos

Head of Immuno-oncology service
Head of Oncology department UNIL CHUV
Director of Ludwig Institute for Cancer Research
+41 21 314 13 57

Curriculum Vitae
Douglas Hanahan

Pr Douglas Hanahan

Director of Institut Suisse de Recherche Expérimentale contre le Cancer (ISREC) at EPFL

Curriculum Vitae
Pierre-Yves Dietrich

Pr Pierre-Yves Dietrich

Head of Oncology department HUG
Professor at the Faculty of Medicine UNIGE

Curriculum Vitae

The CHUV's specificity within the SCCL

The UNIL CHUV Oncology department underpins the SCCL's mission to develop innovative treatments, notably via its immunotherapy programme. Its Immuno-oncology service is dedicated to early phase clinical research. 

SCCL partners of the CHUV

SCCL privileged partners

The SCCL is set in the imposing regional context of the "Health Valley" which includes 450 biotech and 300 medtech firms, 500 biomedical research laboratories and 8 incubators. It is also part of the BioAlps network, backed by the six French-speaking regions of Switzerland, that of Berne (federal government) and the Swiss Confederation. 

 

 Last updated on 05/11/2019 at 14:46